NDC product
up and up omeprazole
NDC 11673-212 · Target Corporation
Key facts
| Product NDC | 11673-212 |
|---|---|
| Proprietary name | up and up omeprazole |
| Nonproprietary name | omeprazole |
| Substances | OMEPRAZOLE |
| Dosage form | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE |
| Route | ORAL |
| Labeler | Target Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | NDA |
| Application number | NDA209400 |
| Pharmacologic classes | Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA] |
| Marketing start | May 9, 2018 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: